Advocacy intelligence hub — real-time data for patient organizations
Revcovi: FDA approved
Treatment of Adenosine Deaminase-Severe Combined Immunodeficiency (ADA-SCID).
Adagen: FDA approved
For enzyme replacement therapy for ADA deficiency in patients with severe combined immunodeficiency.
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Open now
Copay cards
Copay Assistance1
Adagen
Sigma-tau Pharmaceuticals, Inc.
Adagen
(Pegademase bovine)Orphan drugSigma-tau Pharmaceuticals, Inc.
Browse all Short-limb skeletal dysplasia with severe combined immunodeficiency news →
View all Short-limb skeletal dysplasia with severe combined immunodeficiency specialists →